Report

reporttype1receiptdateformat102companynumbUS-009507513-1403USA008346occurcountryUSVersion of Safety Report ID1receivedateformat102duplicate1transmissiondateformat102fulfillexpeditecriteria2Safety Report ID10045627Date Received28/03/2014transmissiondate02/10/2014serious2Date Last Updated28/03/2014primarysourcecountryUS

Receiver

receivertype6receiverorganizationFDA

Primary Source

reportercountryUSqualification3

Sender

sendertype2senderorganizationFDA-Public Use

Patient

Onset Age62Unit of Onset AgeyearsSexMale

Reaction

1)

reactionmeddraversionpt17.0ReactionDry skinOutcomeUnknown

2)

reactionmeddraversionpt17.0ReactionInjection site reactionOutcomeUnknown

3)

reactionmeddraversionpt17.0ReactionInjection site erythemaOutcomeUnknown

4)

reactionmeddraversionpt17.0ReactionNauseaOutcomeUnknown

5)

reactionmeddraversionpt17.0ReactionAstheniaOutcomeUnknown

Drug

1)

drugcharacterization1medicinalproductPEGINTRONdrugauthorizationnumb103949drugstructuredosagenumb.4drugstructuredosageunit012drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition803drugdosagetext0.4 ML, QW, REDIPENdrugdosageformPOWDER FOR INJECTIONdrugadministrationroute058drugindicationHEPATITIS Cdrugstartdateformat102drugstartdate07/03/2014actiondrug4

openFDA Info on Medication

Application NumberBLA103949Brand NamePEGINTRONGeneric NamePEGINTERFERON ALFA-2BManufacturersMerck Sharp & Dohme Corp.product_ndc 0085-1297, 0085-1323, 0085-1316, 0085-1370, 0085-4353, 0085-4354, 0085-4355, 008 ... Product TypeHUMAN PRESCRIPTION DRUGRouteSUBCUTANEOUSActive IngredientsPEGINTERFERON ALFA-2BRXCUI 284192, 284193, 284194, 284195, 731333, 731334, 731345, 731348, 760029, 760039, ... spl_id519a40d2-566f-4d64-8ffb-35813db6c6aespl_set_idb70816bb-913a-467f-acb8-67ef62cf8dacPackage NDC 0085-1323-01, 0085-1323-02, 0085-1316-01, 0085-1316-02, 0085-1297-03, 0085-1297- ... NUIN0000175521, M0025711Established Pharmacologic ClassInterferon alpha [EPC]Chemical StructureInterferon-alpha [CS]UNIIG8RGG88B68

2)

drugcharacterization1medicinalproductREBETOLdrugstructuredosagenumb1drugstructuredosageunit032drugseparatedosagenumb2drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext1 DF, BIDdrugdosageformCAPSULEdrugadministrationroute048drugstartdateformat102drugstartdate07/03/2014actiondrug4

openFDA Info on Medication

Application NumberNDA021546Brand NameREBETOLGeneric NameRIBAVIRINManufacturersMerck Sharp & Dohme Corp.product_ndc0085-1318, 0085-1351, 0085-1385, 0085-1194Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsRIBAVIRINRXCUI248112, 312817, 352007, 544400spl_idc1e62cfb-c88b-4f4a-bfc0-351c71f64062spl_set_id04d2b6f4-bd9b-4871-9527-92c81aa2d4d0Package NDC0085-1351-05, 0085-1385-07, 0085-1194-03, 0085-1318-01NUIN0000175459, N0000175466Established Pharmacologic ClassNucleoside Analog Antiviral [EPC]UNII49717AWG6K

3)

drugcharacterization2medicinalproductSOVALDIdrugstructuredosagenumb400drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext400 MG, QDdrugadministrationroute048drugrecurreadministration3

openFDA Info on Medication

Application NumberNDA204671, NDA212480Brand NameSOVALDIGeneric NameSOFOSBUVIRManufacturersGilead Sciences, Inc.product_ndc61958-1501, 61958-1503, 61958-1504, 61958-1505Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSOFOSBUVIRRXCUI1484916, 1484922, 2203891, 2203893, 2203993, 2203999, 2204090, 2204092spl_idb6ff385d-224a-0bad-e053-2995a90adcd4spl_set_id80beab2c-396e-4a37-a4dc-40fdb62859cfPackage NDC61958-1501-1, 61958-1503-1, 61958-1504-1, 61958-1505-1NUIN0000191493, N0000191258, N0000175459Established Pharmacologic ClassHepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]Mechanism of ActionRNA Replicase Inhibitors [MoA]UNIIWJ6CA3ZU8B

4)

drugcharacterization2medicinalproductZOLOFTdrugstructuredosagenumb100drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext100 MG, QDdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA020990, NDA019839Brand NameZOLOFTGeneric NameSERTRALINE HYDROCHLORIDEManufacturersRoerigproduct_ndc0049-0050, 0049-4960, 0049-4900, 0049-4910Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI208149, 208161, 212233, 312938, 312940, 312941, 861064, 861066spl_id665a145d-44fb-4fef-a3c1-2aac26e0715cspl_set_idfe9e8b7d-61ea-409d-84aa-3ebd79a046b5Package NDC 0049-4960-30, 0049-4960-50, 0049-4900-30, 0049-4900-66, 0049-4900-73, 0049-4900- ... UNIIUTI8907Y6X

5)

drugcharacterization2medicinalproductWELLBUTRINdrugstructuredosagenumb75drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext75 MG, QDdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA021515, NDA020358Brand NameWELLBUTRIN XL, WELLBUTRIN SRGeneric NameBUPROPION HYDROCHLORIDEManufacturersBausch Health US LLC, GlaxoSmithKline LLCproduct_ndc0187-0730, 0187-0731, 0173-0135, 0173-0947, 0173-0722Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsBUPROPION HYDROCHLORIDERXCUI993541, 993545, 993557, 993564, 993503, 993511, 993518, 993528, 993536, 993537spl_ida4bd6e04-f597-4ad4-966d-86cf2efbf5fa, ed416049-f26b-453e-b89a-10bdf7091734spl_set_ida435da9d-f6e8-4ddc-897d-8cd2bf777b21, cbc8c074-f080-4489-a5ae-207b5fadeba3Package NDC 0187-0730-30, 0187-0730-90, 0187-0730-07, 0187-0731-30, 0187-0731-07, 0173-0947- ... UNIIZG7E5POY8O

6)

drugcharacterization2medicinalproductMYSOLINEdrugstructuredosagenumb50drugstructuredosageunit003drugseparatedosagenumb3drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext50 MG, TIDdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA009170Brand NameMYSOLINEGeneric NamePRIMIDONEManufacturersBausch Health US, LLCproduct_ndc66490-690, 66490-691Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsPRIMIDONERXCUI96304, 198150, 201747, 207478spl_id9d9f03b1-4eb4-4ba5-a357-600e368802c6spl_set_idaf593171-dabb-4ea3-b44c-89ed457b2c46Package NDC66490-690-10, 66490-691-10NUIN0000175753, N0000008486Established Pharmacologic ClassAnti-epileptic Agent [EPC]Physiologic/Pharmacodynamic EffectDecreased Central Nervous System Disorganized Electrical Activity [PE]UNII13AFD7670Q

7)

drugcharacterization2medicinalproductNORVASCdrugstructuredosagenumb5drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext5 MG, QDdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA019787Brand NameNORVASCGeneric NameAMLODIPINE BESYLATEManufacturersPfizer Laboratories Div Pfizer Incproduct_ndc0069-1520, 0069-1530, 0069-1540Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsAMLODIPINE BESYLATERXCUI197361, 212542, 212549, 212575, 308135, 308136spl_id3f5ca9a3-9076-49ab-b247-669c337f3364spl_set_idabd6a2ca-40c2-485c-bc53-db1c652505edPackage NDC 0069-1520-68, 0069-1530-68, 0069-1530-41, 0069-1530-72, 0069-1540-68, 0069-1540- ... UNII864V2Q084H

8)

drugcharacterization2medicinalproductBETAPACEdrugstructuredosagenumb80drugstructuredosageunit003drugseparatedosagenumb2drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext80 MG, BIDdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA019865Brand NameBETAPACEGeneric NameSOTALOL HYDROCHLORIDEManufacturersCovis Pharmaproduct_ndc70515-105, 70515-109, 70515-106, 70515-115, 70515-119, 70515-116Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSOTALOL HYDROCHLORIDERXCUI 1922720, 1922721, 1922763, 1922764, 1922765, 1922766, 1923422, 1923423, 1923424, ... spl_idc70abe53-97e1-4f5e-8e76-d207e1f87fe2spl_set_idafce2787-8899-4098-87c8-f1e8dd19e6ddPackage NDC 70515-105-10, 70515-109-10, 70515-106-10, 70515-115-06, 70515-119-06, 70515-116- ... UNIIHEC37C70XX

9)

drugcharacterization2medicinalproductCOUMADINdrugdosagetext1 DAILY EXCEPT WEDNESDAYdrugrecurreadministration3

openFDA Info on Medication

10)

drugcharacterization2medicinalproductCOUMADINdrugdosagetext1/2 TAB ON WEDNESDAYdrugrecurreadministration3

openFDA Info on Medication

11)

drugcharacterization2medicinalproductPLAVIXdrugstructuredosagenumb75drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext75 MG, QDdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA020839Brand NamePLAVIXGeneric NameCLOPIDOGRELManufacturerssanofi-aventis U.S. LLC, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnershipproduct_ndc0024-1171, 0024-1332, 63653-1171, 63653-1332Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsCLOPIDOGREL BISULFATERXCUI213169, 309362, 749196, 749198spl_idcb770afe-b6de-469f-9d9c-3db134394d4d, 12eb3088-f30b-4bb5-aee0-113114b5a08cspl_set_idde8b0b67-eb25-4684-83b5-7ad785314227, 01b14603-8f29-4fa3-8d7e-9d523f802e0bPackage NDC 0024-1171-90, 0024-1332-30, 63653-1171-6, 63653-1171-1, 63653-1171-3, 63653-1171 ... UNII08I79HTP27

12)

drugcharacterization2medicinalproductHYZAARdrugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetextUNK, QDdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA020387Brand NameHYZAARGeneric NameLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDEManufacturersMerck Sharp & Dohme Corp.product_ndc0006-0717, 0006-0745, 0006-0747Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsLOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDERXCUI979464, 979466, 979468, 979470, 979471, 979473spl_id32622632-0367-4cc0-ae2e-21b02371dfcbspl_set_idd3e434b9-2f56-4dec-8cbf-a61e23abcc6aPackage NDC 0006-0717-31, 0006-0717-54, 0006-0717-82, 0006-0745-31, 0006-0745-54, 0006-0745- ... NUIN0000175359, N0000175419, M0471776Physiologic/Pharmacodynamic EffectIncreased Diuresis [PE]Established Pharmacologic ClassThiazide Diuretic [EPC]Chemical StructureThiazides [CS]UNII3ST302B24A, 0J48LPH2TH

13)

drugcharacterization2medicinalproductDILTIAZEM HYDROCHLORIDEdrugstructuredosagenumb120drugstructuredosageunit003drugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext120 MG, QDdrugrecurreadministration3

openFDA Info on Medication

Application Number ANDA203023, ANDA075116, ANDA074185, ANDA205231, ANDA075853, ANDA074941, ANDA0904 ... Brand Name DILTIAZEM HYDROCHLORIDE, DILTIAZEM HCL CD, DILTIAZEM HYDROCHLORIDE EXTENDED RELE ... Generic NameDILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETSManufacturers Sun Pharmaceutical Industries, Inc., OCEANSIDE PHARMACEUTICALS, Teva Pharmaceuti ... product_ndc 63304-718, 63304-719, 63304-720, 63304-721, 63304-722, 68682-993, 68682-994, 686 ... Product TypeHUMAN PRESCRIPTION DRUGRouteORAL, INTRAVENOUSActive IngredientsDILTIAZEM HYDROCHLORIDERXCUI 830795, 830801, 830837, 830845, 830861, 831054, 831102, 831103, 833217, 1791229, ... spl_id f9671b7a-bf1b-45f5-8d2e-cb834f7395a5, 7ba020e2-1dbc-42f4-8bcd-02cabaacf3a9, 46e3 ... spl_set_id 976d9dd0-4f11-4439-b84e-0c0f0e018d8b, 43892b97-449d-45bc-bb09-29d47c655d65, 69ca ... Package NDC 63304-718-30, 63304-718-05, 63304-718-90, 63304-719-30, 63304-719-05, 63304-719- ... UNIIOLH94387TE

14)

drugcharacterization2medicinalproductPROTONIXdrugdosagetextONE TABLET 30 MINUTES BEFORE FOOD IN THE MORNINGdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA020988, NDA020987, NDA022020Brand NamePROTONIX I.V., PROTONIX DELAYED-RELEASEGeneric NamePANTOPRAZOLE SODIUMManufacturersWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.product_ndc0008-0923, 0008-2001, 0008-4001, 0008-0841, 0008-0843, 0008-0844Product TypeHUMAN PRESCRIPTION DRUGRouteINTRAVENOUS, ORALActive IngredientsPANTOPRAZOLE SODIUMRXCUI283669, 885257, 251872, 284400, 314200, 352125, 763306, 763308spl_id b326d5db-8b20-4ec4-ac25-78190fb3ac36, 1e8fa399-506d-4bcd-9097-dbf7850147bf, 7bdf ... spl_set_id 51e4144a-489e-436c-609a-39305f8f56ba, 5b5ddedd-d429-41a7-8573-10c3e9ad4e52, f39b ... Package NDC 0008-0923-51, 0008-0923-60, 0008-0923-55, 0008-2001-01, 0008-2001-25, 0008-2001- ... UNII6871619Q5X

15)

drugcharacterization2medicinalproductNEURONTINdrugdosagetextTWO PILLS THREE TIMES A DAYdrugrecurreadministration3

openFDA Info on Medication

Application NumberNDA020882, NDA020235, NDA021129Brand NameNEURONTINGeneric NameGABAPENTINManufacturersParke-Davis Div of Pfizer Incproduct_ndc0071-0401, 0071-0803, 0071-0805, 0071-0806, 0071-0513, 0071-2012Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsGABAPENTINRXCUI 105028, 105029, 105030, 261280, 261281, 283523, 310430, 310431, 310432, 310433, ... spl_id597965f8-e2d2-4010-b57b-482f6e59a810spl_set_idee9ad9ed-6d9f-4ee1-9d7f-cfad438df388Package NDC 0071-0803-24, 0071-0803-40, 0071-0805-24, 0071-0805-40, 0071-0806-24, 0071-0806- ... NUIN0000175753, N0000008486Established Pharmacologic ClassAnti-epileptic Agent [EPC]Physiologic/Pharmacodynamic EffectDecreased Central Nervous System Disorganized Electrical Activity [PE]UNII6CW7F3G59X

Report Duplicate

duplicatesourceMERCKduplicatenumbUS-009507513-1403USA008346

Adverse Event Report

Report

Receiver

Primary Source

Sender

Patient

Reaction

1)

2)

3)

4)

5)

Drug

1)

openFDA Info on Medication

2)

openFDA Info on Medication

3)

openFDA Info on Medication

4)

openFDA Info on Medication

5)

openFDA Info on Medication

6)

openFDA Info on Medication

7)

openFDA Info on Medication

8)

openFDA Info on Medication

9)

openFDA Info on Medication

10)

openFDA Info on Medication

11)

openFDA Info on Medication

12)

openFDA Info on Medication

13)

openFDA Info on Medication

14)

openFDA Info on Medication

15)

openFDA Info on Medication

Report Duplicate

Media

Newsletter

Follow us

Connect with us